- Home
- FVCB vs ARCT Comparison
FVCB vs ARCT Comparison
Compare FVCB & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FVCB | ARCT |
|---|---|---|
| Founded | 2007 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 338.0M | 293.9M |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FVCB | ARCT |
|---|---|---|
| Price | $16.23 | $10.29 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | $19.38 | ★ $23.80 |
| AVG Volume (30 Days) | 74.9K | ★ 636.5K |
| Earning Date | 10-22-2026 | 11-05-2026 |
| Dividend Yield | ★ 1.72% | N/A |
| EPS Growth | ★ 47.56 | 20.00 |
| EPS | ★ 0.81 | N/A |
| Revenue | $1,781,000.00 | ★ $82,031,000.00 |
| Revenue This Year | $19.14 | N/A |
| Revenue Next Year | $9.11 | $54.47 |
| P/E Ratio | $20.78 | ★ N/A |
| Revenue Growth | ★ 13.87 | N/A |
| 52 Week Low | $12.13 | $5.50 |
| 52 Week High | $19.11 | $17.96 |
Technical Indicators
Market Signals| Indicator | FVCB | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 28.58 | 45.33 |
| Support Level | $15.34 | $6.53 |
| Resistance Level | $16.26 | $12.44 |
| Average True Range (ATR) | 0.58 | 1.07 |
| MACD | -0.09 | -0.02 |
| Stochastic Oscillator | 7.05 | 37.25 |
Price Performance
Historical ComparisonAbout FVCB FVCBankcorp Inc.
FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.